Injection of Hyaluronic Acid versus Corticosteroid in Management of Plantar Fasciitis: Randomized Clinical Trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR202401785557046

Enrollment

Registered

2024-01-18

Start date

2024-03-04

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal Diseases

Interventions

Injection of Hyaluronic Acid

Corticosteroid injection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Age: 20 and 60 years Chronic talalgia (3 months), resistant to conservative treatment: rest, insoles, physical treatment (such as deep transverse massages, stretching, shock waves, etc.), and NSAIDs. Clinical diagnosis of PA: Pain initiated or aggravated by exertion and pain on palpation of the enthesis. Absence of fissures detected in ultrasound examinations. Visual Analog Scale (VAS) pain > 3/10

Exclusion criteria

Exclusion criteria: Plantar fascia surgery Shock waves within the last 3 months A corticosteroid or PRP injection in the last 3 months Bilateral plantar fasciitis Uncontrolled diabetes mellitus Chronic inflammatory rheumatism (spondyloarthritis) Tarsal tunnel syndrome Infection or local trauma near the injection site.

Design outcomes

Primary

Measure	Time frame
Pain intensity will be assessed by : The Visual Analogue Scale (VAS)	—

Secondary

Measure	Time frame
Function will be assessed by : Roles and Maudsley score and Functional Foot Index (FFI); Ultrasound evaluation: Measurement of AP thickness / Absence of fissures;Patient satisfaction using Satisfaction likert scale;Complications: Fissure/rupture, infection	—

Countries

Morocco

Contacts

Public ContactNihad Takhrifa

Mohammed VI University Hospital

Nihadtakhrifa@gmail.com+212642286993

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026